Literature DB >> 22033023

Radiation dose estimates for carbon-11-labelled PET tracers.

Jasper van der Aart1, William A Hallett, Eugenii A Rabiner, Jan Passchier, Robert A Comley.   

Abstract

INTRODUCTION: Carbon-11-labelled positron emission tomography (PET) tracers commonly used in biomedical research expose subjects to ionising radiation. Dosimetry is the measurement of radiation dose, but also commonly refers to the estimation of health risk associated with ionising radiation. This review describes radiation dosimetry of carbon-11-labelled molecules in the context of current PET research and the most widely used regulatory guidelines.
METHODS: A MEDLINE literature search returned 42 articles; 32 of these were based on human PET data dealing with radiation dosimetry of carbon-11 molecules. Radiation burden expressed as effective dose and maximum absorbed organ dose was compared between tracers.
RESULTS: All but one of the carbon-11-labelled PET tracers have an effective dose under 9 μSv/MBq, with a mean of 5.9 μSv/MBq. Data show that serial PET scans in a single subject are feasible for the majority of radiotracers.
CONCLUSION: Although differing in approach, the two most widely used regulatory frameworks (those in the USA and the EU) do not differ substantially with regard to the maximum allowable injected activity per PET study. The predictive validity of animal dosimetry models is critically discussed in relation to human dosimetry. Finally, empirical PET data are related to human dose estimates based on homogenous distribution, generic models and maximum cumulated activities. Despite the contribution of these models to general risk estimation, human dosimetry studies are recommended where continued use of a new PET tracer is foreseen.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22033023     DOI: 10.1016/j.nucmedbio.2011.08.005

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  19 in total

1.  Biodistribution and radiation dosimetry of the serotonin 5-HT₆ ligand [¹¹C]GSK215083 determined from human whole-body PET.

Authors:  Robert A Comley; Cristian Salinas; Romina Mizrahi; Irina Vitcu; Alvina Ng; William Hallett; Nicholas Keat; Alan A Wilson; Eugenii A Rabiner; Marc Laruelle; Sylvain Houle
Journal:  Mol Imaging Biol       Date:  2012-08       Impact factor: 3.488

2.  Radiation dosimetry and biodistribution of the translocator protein radiotracer [(11)C]DAA1106 determined with PET/CT in healthy human volunteers.

Authors:  Arthur L Brody; Kyoji Okita; Jennifer Shieh; Lidia Liang; Robert Hubert; Michael Mamoun; Judah Farahi; Mark A Mandelkern
Journal:  Nucl Med Biol       Date:  2014-08-01       Impact factor: 2.408

3.  Human Radiation Dosimetry for the N-Methyl-D-Aspartate Receptor Radioligand 11C-CNS5161.

Authors:  Vijay Dhawan; William Robeson; David Bjelke; Thomas Chaly; Kristin Graf; Matthew Hellman; Limei Zhuo; Meggan Mackay; David Eidelberg
Journal:  J Nucl Med       Date:  2015-04-30       Impact factor: 10.057

4.  High Enantiomeric Excess In-Loop Synthesis of d-[methyl-11C]Methionine for Use as a Diagnostic Positron Emission Tomography Radiotracer in Bacterial Infection.

Authors:  Megan N Stewart; Matthew F L Parker; Salma Jivan; Justin M Luu; Tony L Huynh; Brailee Schulte; Youngho Seo; Joseph E Blecha; Javier E Villanueva-Meyer; Robert R Flavell; Henry F VanBrocklin; Michael A Ohliger; Oren Rosenberg; David M Wilson
Journal:  ACS Infect Dis       Date:  2019-11-21       Impact factor: 5.084

5.  A multi species evaluation of the radiation dosimetry of [11C]erlotinib, the radiolabeled analog of a clinically utilized tyrosine kinase inhibitor.

Authors:  J Ryan Petrulli; Søren B Hansen; Galith Abourbeh; Maqsood Yaqub; Idris Bahce; Daniel Holden; Yiyun Huang; Nabeel B Nabulsi; Joseph N Contessa; Eyal Mishani; Adriaan A Lammertsma; Evan D Morris
Journal:  Nucl Med Biol       Date:  2017-01-02       Impact factor: 2.408

6.  Suggested pathway to assess radiation safety of ¹⁸F-labeled PET tracers for first-in-human studies.

Authors:  Paolo Zanotti-Fregonara; Adriaan A Lammertsma; Robert B Innis
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-07-19       Impact factor: 9.236

7.  Whole-body biodistribution and radiation dosimetry of the cannabinoid type 2 receptor ligand [11C]-NE40 in healthy subjects.

Authors:  Rawaha Ahmad; Michel Koole; Nele Evens; Kim Serdons; Alfons Verbruggen; Guy Bormans; Koen Van Laere
Journal:  Mol Imaging Biol       Date:  2013-08       Impact factor: 3.488

8.  Preclinical safety assessment of the 5-HT2A receptor agonist PET radioligand [ 11C]Cimbi-36.

Authors:  Anders Ettrup; Søren Holm; Martin Hansen; Muhammad Wasim; Martin Andreas Santini; Mikael Palner; Jacob Madsen; Claus Svarer; Jesper Langgaard Kristensen; Gitte Moos Knudsen
Journal:  Mol Imaging Biol       Date:  2013-08       Impact factor: 3.488

Review 9.  Radiation Absorbed Dose to the Embryo and Fetus from Radiopharmaceuticals.

Authors:  Paolo Zanotti-Fregonara
Journal:  Semin Nucl Med       Date:  2022-01-21       Impact factor: 4.446

10.  11C-LY2428703, a positron emission tomographic radioligand for the metabotropic glutamate receptor 1, is unsuitable for imaging in monkey and human brains.

Authors:  Paolo Zanotti-Fregonara; Vanessa N Barth; Sami S Zoghbi; Jeih-San Liow; Eric Nisenbaum; Edward Siuda; Robert L Gladding; Denise Rallis-Frutos; Cheryl Morse; Johannes Tauscher; Victor W Pike; Robert B Innis
Journal:  EJNMMI Res       Date:  2013-06-10       Impact factor: 3.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.